Piper Sandler Downgrades CareMax to Neutral, Announces $2 Price Target
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jessica Tassan has downgraded CareMax (NASDAQ:CMAX) from Overweight to Neutral and set a price target of $2.
November 10, 2023 | 12:11 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CareMax has been downgraded from Overweight to Neutral by Piper Sandler, with a new price target of $2.
The downgrade from Overweight to Neutral by Piper Sandler indicates a less optimistic outlook for CareMax. The new price target of $2 also suggests a potential decrease in the stock's value. This could negatively impact the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100